A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Methods for Selective Expansion of γδ T‑Cell Populations and Compositions Thereof
Assignee: Adicet Bio, Inc.Patent Number: 11,299,708 B2Priority (Filing) Date: May 12, 2016Issued: April 12, 2022 (in force through 2025 and likely beyond)Title: Methods for Selective Expansion of γδ T‑Cell Populations and Compositions Thereof What This Patent Covers This patent safeguards…
-
Virus‑Like Particle Conjugates for Diagnosis and Treatment of Tumors
Assignee: Aura Biosciences, Inc. and U.S. Government (NCI/NIH)Patent Number: US 11,806,406 B2Filed: August 5, 2021Issued: November 7, 2023Title: Virus‑like particle conjugates for diagnosis and treatment of tumors What This Patent Covers This patent protects novel virus‑like particle (VLP) drug conjugates —…
-
Programmable Cell Therapies: Logic-Gated CAR-T Cells and the Patentability of Engineered Cellular Decision-Making
Cell engineering has moved beyond simple expression of therapeutic proteins toward the construction of programmable living systems. In the context of cancer immunotherapy, this shift is most visible in next-generation chimeric antigen receptor (CAR) T…
BioTech IP Review 